Hayek Kallen Investment Management purchased a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 24,059 shares of the company’s stock, valued at approximately $3,092,000.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Bank of America Corp DE bought a new stake in Merck KGaA during the second quarter valued at approximately $3,923,774,000. Legal & General Group Plc purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at $2,425,225,000. Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at $942,087,000. Caisse de depot et placement du Quebec bought a new stake in shares of Merck KGaA during the 2nd quarter worth $571,582,000. Finally, Canada Pension Plan Investment Board bought a new stake in shares of Merck KGaA during the 2nd quarter worth $536,694,000. 0.10% of the stock is owned by hedge funds and other institutional investors.
Merck KGaA Stock Down 3.9%
Shares of OTCMKTS:MKGAF opened at $158.15 on Friday. The firm has a market capitalization of $20.44 billion, a PE ratio of 24.14 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56. The firm has a fifty day moving average of $163.21 and a 200 day moving average of $148.95.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
